RISK FACTORS FOR DEVELOPMENT OF NEOVASCULAR GLAUCOMA AFTER MINIINVASIVE DIABETIC VITRECTOMY IN PATIENTS WITH POLIFERATIVE DIABETIC RETINOPATHY

Authors

  • A. N. Ruban National Medical Academy of Postgraduate Education by P. L. Shupyk

DOI:

https://doi.org/10.11603/mie.1996-1960.2014.3.3807

Abstract

The article presents the risk factors for neovascular glaucoma in patients after miniinvasive diabetic vitrectomy. This was a retrospective study of 237 eyes (237 patients) who underwent combined sutureless vitrectomy 23/25G for the complications of proliferative diabetic retinopathy. Indications for the surgery were vitreous hemorrhage and tractional retinal detachment. The main predictive clinical features of neovascular glaucoma after diabetic vitrectomy were: previously not performed laser phothocoagulation, level of HbA1 c >8 %, neovascular glaucoma contralateral eye, neovascularization of iris, type of diabetis, sex, vitreous hemorrhage, “table-type” of fractional retinal detachment, Marcus-Gunn defect, size of nonperfusion >2 quadrants, previously not injected inhibitor of VEGF.

References

Cheung N. Diabetic retinopathy / N. Cheung, P. Mitchell, T. Y. Wong // Lancet. - 2010. - № 376. - P. 124-136.

Klein R.Arch/ R. Klein, E Moss, M. Davis // Ophthalmol. - 1984.-Ns 102 (4).-P. 520-526.

OshimaY. Surgical outcomes of 25-gauge transconjunctival vitrectomy combined with cataract surgery for vitreoretinal diseases / Y. Oshima, M. Ohji, Y. Tano // Ann. Acad. Med. Singapore.-2006.-№35.-P. 175-180.

Long-term followup of vitrectomy for diffuse nontractional diabetic macular edema / Kumagai K., Furukawa M., N. Ogino [et al.] // Retina. - 2009. -№ 29. - P 464-472.

Summanen P. Neovascular glaucoma following vitrectomy for diabetic eye disease / P. Summanen //Acta Ophthalmol. - 1988.-N66.-P. 110-116.

Aaberg T. M. Late complications of pars plana vitreous surgery / T. M. Aaberg, D. L. Van Horn // Ophthalmology. - 1978.-N85.-P. 126-140.

Blankenship G. W. Long-term diabetic vitrectomy results. Report of10 year follow-up / G. W. Blankenship, R. Machemer Long// Ophthalmology. -1985.-№ 92.-P 503-506.

Py6aH A. M. Pe3ynbTaTH комбінованої 23G вітректомії з факоемульсифікацією та імплантацією ІОЛ у пацієнтів на проліферативну діабетичну ретинопатію / A. M. Pyбaн // Офтальмологічний журнал.-№2,2013. - С. 36-42.

Pyбaн A. M. Бімануальна мініінвазивна техніка видалення заднього вітреошизису у пацієнтів на проліферативну діабетичну ретинопатію / A. M. Pyбaн // Зб. наук. праць співробіт. НМАПО імені П. Л. Шупика. - 2013. - № 22 (4). - С. 90-98.

Oldendoerp J. Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus / J. Oldendoerp, M. Spitznas // Graefes.Arch.Clin.Exp. Ophthalmol.-1989.-№227.- P. 1-8.

Sima P. Long-term results of vitreous surgery for proliferative diabetic retinopathy / P. Sima, T. Zoran // Doc Ophthalmol.- 1994-N 87.-P.223-232.

Scuderi J. J. Regression of diabetic rubeosis iridis following successful surgical reattachment of the retina by vitrectomy / J. J. Scuderi, M. S. Blumenkranz, G. Blankenship // Retina. - 1982.-№2.-P. 193-196.

Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy / A. Goto [etal.] //J. Glaucoma.- 2013.-Sep.22(7).-P.572- 576.

Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure /Y. Takihara, M. Inatani, M. Fukushima [et al.] //Am. J. Ophthalmol. - 2009. -№147.-P. 912-918.

Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma / Y. Takihara, M. Inatani, T. Kawaji [et al.] // J. Glaucoma. -2011.-№ 20.-P 196-201.

Long-term results of Molteno implant insertion in cases of neovascular glaucoma/ S. G. Every,A. C. Molteno, T. H. Bevin [et al.] //Arch Ophthalmol. - 2006. -№ 124. - P. 355-360.

Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis / M. Reeves,A.Bhatt,P. Jajou[etal.] //Stroke.-2009.-№40. -P. 1743-1749.

Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management / M. Boulton, Z. Gregor, D. McLeod [et al.] //Br. J. Ophthalmol.- 1997.-J№ 81.-P. 228-233.

Aiello L. P. Sytemic considerations in the management of diabetic retinopathy / L. P. Aiello, M. T. Cahill, J. S. Wong // Am. J. Ophthalmol. - 2001. - №° 132.-P. 760-776.

Py6aн A. M. Ефективність міні-інвазивноївітректомії з ендотампонадою силіконом у хворих на проліферативну діабетичну ретинопатію (У друку).

Pодин С. С. Бевацизумаб (авастин) в комплексном хирургическом лечении больных с пролиферативной стадией диабетической ретинопатии/ С. Сходин, В. С. Асланова // Український медичний альманах. - Луганск. - 2008. - Т. 11, №а3.-С. 126-128.

Downloads

Published

2015-05-14

How to Cite

Ruban, A. N. (2015). RISK FACTORS FOR DEVELOPMENT OF NEOVASCULAR GLAUCOMA AFTER MINIINVASIVE DIABETIC VITRECTOMY IN PATIENTS WITH POLIFERATIVE DIABETIC RETINOPATHY. Medical Informatics and Engineering, (3). https://doi.org/10.11603/mie.1996-1960.2014.3.3807

Issue

No. 3 (2014)

Section

Articles

License

Journal Medical Informatics and Engineering  allows the author(s) to hold the copyright without registration

 

The majority of Medical Informatics and Engineering Open Access journals publish open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited. The remaining journals offer a choice of licenses.

 Результат пошуку зображень за запитом "CC-BY logo"

This journal is available through Creative Commons (CC) License  CC-BY 4.0